Deucravacitinib by Bristol-Myers Squibb can help with psoriasis, psoriatic arthritis, Crohn’s disease, ulcerative colitis, and systemic lupus erythematosus.
Teclistamab by Johnson & Johnson is a new hope for refractory or relapsing multiple myeloma.
Daridorexant will help treat insomnia.
Omicron, a new variant of the SARS-CoV-2 coronavirus, will infect nearly 40% of the world’s population.
Efgartigimod developed by Argenx is a strong competitor to Soliris.
Up-to-date scientific information about the new Omicron variant of SARS-CoV-2/COVID-19.
Oral ozanimod will provide clinical remission of ulcerative colitis for a third of patients.